Do you want to read an article? Please log in or register.
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
Diabetes - GeneralType 2 Diabetes